In particular, the activation of the NRF2‒HO-1 axis is now proposed to be a candidate to treat COVID-19 patients [46,47,48], and A. lavenia extract has been shown to ameliorate the pathogenesis of a model pneumonia induced by lipopolysaccharides [2]. This evidence concerns the gene NFE2L2 and pneumonia.